Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) — Cash Flow Quality Index
Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) has a Cash Flow Quality Index of 0.17x as of September 2025. Operating cash flow of CN¥117.38 Million is below net income of CN¥687.04 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Zhangzhou Pientzehuang Pharmaceutical Co (600436) investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Cash Flow Quality Index (2001–2025)
Historical Cash Flow Quality Index for Zhangzhou Pientzehuang Pharmaceutical Co Ltd across 25 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Zhangzhou Pientzehuang Pharmaceutical Co (600436) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Zhangzhou Pientzehuang Pharmaceutical Co Ltd (2001–2025)
Year-by-year earnings quality comparison for Zhangzhou Pientzehuang Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see how much is Zhangzhou Pientzehuang Pharmaceutical Co worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | CN¥77.03 Million | CN¥2.16 Billion | ▼ -91.9% |
| 2024 | 0.44x | CN¥1.31 Billion | CN¥3.00 Billion | ▼ -43.3% |
| 2023 | 0.77x | CN¥2.21 Billion | CN¥2.85 Billion | ▼ -71.6% |
| 2022 | 2.72x | CN¥6.87 Billion | CN¥2.52 Billion | ▲ +1352.0% |
| 2021 | 0.19x | CN¥462.27 Million | CN¥2.46 Billion | ▼ -78.4% |
| 2020 | 0.87x | CN¥1.47 Billion | CN¥1.69 Billion | ▲ +237.0% |
| 2019 | -0.63x | CN¥-879.37 Million | CN¥1.39 Billion | ▼ -216.9% |
| 2018 | 0.54x | CN¥612.31 Million | CN¥1.13 Billion | ▼ -37.5% |
| 2017 | 0.87x | CN¥676.93 Million | CN¥780.43 Million | ▲ +11.4% |
| 2016 | 0.78x | CN¥394.54 Million | CN¥506.82 Million | ▲ +18.1% |
| 2015 | 0.66x | CN¥305.51 Million | CN¥463.34 Million | ▲ +9.2% |
| 2014 | 0.60x | CN¥264.50 Million | CN¥437.89 Million | ▼ -5.1% |
| 2013 | 0.64x | CN¥274.34 Million | CN¥431.10 Million | ▲ +37.4% |
| 2012 | 0.46x | CN¥162.40 Million | CN¥350.58 Million | ▼ -49.0% |
| 2011 | 0.91x | CN¥232.95 Million | CN¥256.54 Million | ▼ -13.9% |
| 2010 | 1.06x | CN¥205.41 Million | CN¥194.70 Million | ▲ +6.1% |
| 2009 | 0.99x | CN¥129.52 Million | CN¥130.25 Million | ▲ +1020.4% |
| 2008 | 0.09x | CN¥12.57 Million | CN¥141.67 Million | ▼ -85.7% |
| 2007 | 0.62x | CN¥60.04 Million | CN¥96.40 Million | ▲ +2.9% |
| 2006 | 0.61x | CN¥50.70 Million | CN¥83.81 Million | ▼ -23.6% |
| 2005 | 0.79x | CN¥69.06 Million | CN¥87.18 Million | ▼ -66.4% |
| 2004 | 2.36x | CN¥98.67 Million | CN¥41.90 Million | ▲ +340.9% |
| 2003 | 0.53x | CN¥32.36 Million | CN¥60.57 Million | ▼ -70.2% |
| 2002 | 1.79x | CN¥105.45 Million | CN¥58.79 Million | ▲ +42.1% |
| 2001 | 1.26x | CN¥65.84 Million | CN¥52.16 Million | — |